CVS Health (CVS) Tops Q3 EPS by 44c, Beats on Revenue; Offers FY26 EPS Guidance

Go back to CVS Health (CVS) Tops Q3 EPS by 44c, Beats on Revenue; Offers FY26 EPS Guidance

CVS Health Announces Intent to Create Two Distinct Leaders in Healthcare

November 4, 2026 6:31 AM EST

A leading healthcare solutions company with health benefits, pharmacy services and care delivery The leading national retail pharmacy and community healthcare company Ongoing strategic execution creates opportunity for CVS Health to evolve into two companies with greater focus and more value for stakeholders Will continue to improve affordability, access, and simplicity in healthcare Both companies expected to have a solid investment grade rating, with strong free cash flow... More

CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE

November 4, 2026 6:30 AM EST

Third quarter total revenues increased to $108.4 billion, up 5.4% year-over-year Third quarter GAAP diluted EPS of $1.68 and Adjusted EPS of $2.09 Generated year-to-date cash flow from operations of $15.3 billion Raising full-year 2026 guidance:GAAP diluted EPS guidance to at least $6.98 from a range of $6.84 to $7.04Adjusted EPS guidance to at least $8.20 from a range of $7.90 to $8.10Cash flow from operations guidance to at least $15.5 billion from at... More